Blood Collection From Adults With Cancer Before and After Chemotherapy
Collects blood from adults with cancer to study immune-suppressing cells around chemotherapy.
Key facts
- Who runs it
- National Cancer Institute (NCI)
- Where
- Bethesda, United StatesSee the site
- Trial code
- Registry title
- Collection of Blood From Patients With Cancer
- Status
- Recruiting
- People taking part
- 1,750 people, planned
- Started
- 16 Jul 2002
- Type of study
- Observational, 2 groups
- Record updated
- 9 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a known or suspected cancer, and also healthy volunteers. It collects blood samples. No treatment is given in this study.
- Age
- 18 years and older
- Sex
- All sexes can join.
- Disease stage
- A known or suspected malignancy (cancer); the record names prostate, breast, colon, lung and liver cancer.
Main reasons for not taking part
- For the apheresis part (no longer asked): hemoglobin below 10 mg/dL or platelet count of 75,000/mm(3) or less
- For the apheresis part: weight of 25 kg (55 lb) or less
- For the apheresis part: HIV positive
The registry criteria, word for word
Show all 2 criteriaShow less
Who cannot take part
- None
Other criteria
- INCLUSION CRITERIA:; Patients with a known or suspected malignancy and healthy volunteers 18 years of age and older are eligible; Performance status of ECOG 0, 1, 2, or 3 for admission to this protocol; Ability to understand and the willingness to sign a written informed consent document; INCLUSION FOR APHERESIS:; Note: Effective with Amendment CC, participants will no longer be asked to undergo apheresis. This content is being retained for historical reference; Hemoglobin greater than or equal to 10 mg/dL and platelet count > 75,000/mm(3); Weight greater than 25 kg; HIV negative; Prothrombin Time - within normal limits; Partial Thromboplastin Time - within normal limits; Medically indicated central line in place or adequate peripheral venous access
Where in United States
- National Institutes of Health Clinical CenterBethesda, United StatesContact: National Cancer Institute Referral OfficeTaking people
About the trial
What the trial wants to find out
This study will collect blood from patients with cancer to study the level of cells which decrease the immune response (suppressor cells) before and after chemotherapy. Patients 18 years of age and older with cancer may participate. This study does not involve treatment.
Read full original descriptionShow less
Participants will have about 50 ml (3 tablespoonfuls) of blood drawn. Depending on their condition, patients may be invited to enroll in a clinical research study involving chemotherapy, radiotherapy, or surgery. Additional 40-ml blood samples may be drawn during the course of treatment.
The 2 groups in the trial
- Healthy Volunteers
Healthy volunteers 18 years of age and older
- Participants
Participants with cancer 18 years of age and older
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Biospecimen Acquisition From Human Subjects
- Plain-language title
- Blood Collection From Adults With Cancer Before and After ChemotherapyGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 9 November 2026